“With the projected cash-sparing benefits accruing from the MD Anderson alliance the Company believes that cash and marketable securities, which were approximately $17.9 million as of March 31, 2019, will be sufficient to finance operations through the end of 2020.”
If this is true, then there shouldn’t be any offerings or dilution in the near future.....
News 
Market Data 
Discover 
